Giuseppe Sanguineti

10.6k total citations
231 papers, 5.8k citations indexed

About

Giuseppe Sanguineti is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Radiation. According to data from OpenAlex, Giuseppe Sanguineti has authored 231 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Pulmonary and Respiratory Medicine, 113 papers in Otorhinolaryngology and 73 papers in Radiation. Recurrent topics in Giuseppe Sanguineti's work include Head and Neck Cancer Studies (113 papers), Advanced Radiotherapy Techniques (73 papers) and Prostate Cancer Diagnosis and Treatment (43 papers). Giuseppe Sanguineti is often cited by papers focused on Head and Neck Cancer Studies (113 papers), Advanced Radiotherapy Techniques (73 papers) and Prostate Cancer Diagnosis and Treatment (43 papers). Giuseppe Sanguineti collaborates with scholars based in Italy, United States and Malaysia. Giuseppe Sanguineti's co-authors include C. Fiorino, Todd McNutt, Binbin Wu, Francesco Ricchetti, R. Valdagni, T. Rancati, F. Foppiano, Eugene J. Endres, Adam S. Garden and Renzo Corvò and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Giuseppe Sanguineti

215 papers receiving 5.7k citations

Peers

Countries citing papers authored by Giuseppe Sanguineti

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Sanguineti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Sanguineti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Sanguineti more than expected).

Fields of papers citing papers by Giuseppe Sanguineti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Sanguineti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Sanguineti. The network helps show where Giuseppe Sanguineti may publish in the future.

Co-authorship network of co-authors of Giuseppe Sanguineti

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Sanguineti. A scholar is included among the top collaborators of Giuseppe Sanguineti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Sanguineti. Giuseppe Sanguineti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dosimetric and NTCP advantages of robust proton therapy over robust VMAT for Stage III NSCLC in the immunotherapy era 2024 ·Physica Medica ·Francesco Dionisi, Valeria Landoni, (unknown), (unknown), Francesco Fracchiolla, (unknown), A. Soriani, (unknown), Roberto Righetto, Dante Amelio, Paolo Farace, (unknown), (unknown), Stefano Lorentini, Marco Cianchetti, Giuseppe Sanguineti	2
2	A Customized 3D-Printed Bolus for High-Risk Breast Cancer with Skin Infiltration: A Pilot Study 2024 ·Current Oncology ·(unknown), (unknown), Paola Pinnarò, E. Infusino, Laura Marucci, A. Soriani, Giuseppe Sanguineti, Giuseppe Iaccarino	1
3	Breast and cervical cancer in transgender men: literature review and a case report 2024 ·Therapeutic Advances in Medical Oncology ·(unknown), (unknown), (unknown), (unknown), Benito Chiofalo, Giuseppe Sanguineti, Laura Pizzuti, Eriseld Krasniqi, Maddalena Barba, Domenico Sergi, Francesco Lombardo, Francesco Romanelli, Claudio Botti, Giovanni Zoccali, Gennaro Ciliberto, Patrizia Vici	2
4	SBRT in 3 Fractions for T1 Glottic Cancer 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Giuseppe Sanguineti, (unknown), Marta Bottero, Alessia Farneti, Diana Giannarelli, Alessio Signori, Valeria Landoni	1
5	Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation 2023 ·La radiologia medica ·Francesco Dionisi, (unknown), (unknown), Giuseppe Iaccarino, Alessia Farneti, (unknown), (unknown), (unknown), (unknown), Elisa D’Angelo, (unknown), Giuseppe Fanetti, Liliana Belgioia, Daniela Alterio, Ester Orlandi, Anna Merlotti, Daniela Musio, Giuseppe Sanguineti	4
6	Partial Laryngectomy for pT4a Laryngeal Cancer: Outcomes and Limits in Selected Cases 2023 ·Cancers ·Giovanni Succo, Andy Bertolin, Izabella Costa Santos, (unknown), Marco Lionello, Marco Fantini, (unknown), Ilaria Bertotto, Andrea Elio Sprio, Giuseppe Sanguineti, Fernando Luiz Dias, Giuseppe Rizzotto, Erika Crosetti	7
7	Current management and future challenges in salivary glands cancer 2023 ·Frontiers in Oncology ·Laura D. Locati, Renata Ferrarotto, Lisa Licitra, Marco Benazzo, Lorenzo Preda, Davide Farina, Gemma Gatta, Davide Lombardi, Piero Nicolai, Vincent Vander Poorten, Melvin L.K. Chua, Barbara Vischioni, Giuseppe Sanguineti, Patrizia Morbini, Isabel Fonseca, Davide Sozzi, Anna Merlotti, Ester Orlandi	11
8	The Prognostic Value of DCE-MRI Findings before Salvage Radiotherapy after Radical Prostatectomy 2023 ·Cancers ·Alessia Farneti, Marta Bottero, Adriana Faiella, Diana Giannarelli, Luca Bertini, Valeria Landoni, Patrizia Vici, (unknown), Giuseppe Sanguineti	0
9	Multifactorial Model Based on DWI-Radiomics to Determine HPV Status in Oropharyngeal Squamous Cell Carcinoma 2022 ·Applied Sciences ·Simona Marzi, Francesca Piludu, (unknown), (unknown), Giuseppe Sanguineti, Alessia Farneti, (unknown), Maria Benevolo, Francesca Rollo, Renato Covello, Francesco Mazzola, Antonello Vidiri	7
10	Consolidative active scanning proton therapy for mediastinal lymphoma: selection criteria, treatment implementation and clinical feasibility 2022 ·Strahlentherapie und Onkologie ·Francesco Dionisi, Daniele Scartoni, Barbara Rombi, Sabina Vennarini, Roberto Righetto, Paolo Farace, Stefano Lorentini, Marco Schwarz, (unknown), (unknown), Rolando Maria D’Angelillo, (unknown), Giuseppe Sanguineti, Maurizio Amichetti	2
11	Predictors of Patient-Reported Incontinence at Adjuvant/Salvage Radiotherapy after Prostatectomy: Impact of Time between Surgery and Radiotherapy 2021 ·Cancers ·Fernando Muñoz, Giuseppe Sanguineti, (unknown), Domenico Cante, V. Vavassori, (unknown), Giuseppe Girelli, B. Avuzzi, E. Garibaldi, Adriana Faiella, E. Villa, Alessandro Magli, B. Noris Chiorda, Marco Gatti, T. Rancati, R. Valdagni, N.G. Di Muzio, C. Fiorino, C. Cozzarini	2
12	The Impact of Post-Operative Radiotherapy in Early Stage (pT1-pT2N0M0) Oral Tongue Squamous Cell Carcinoma in Era of DOI 2021 ·Cancers ·Daniela Alterio, (unknown), Stefania Volpe, Marta Tagliabue, Rita De Berardinis, Matteo Augugliaro, Sara Gandini, Fausto Maffini, Roberto Bruschini, (unknown), Stefano Riccio, Luca Calabrese, Alessia Farneti, Anna Starzyńska, Annamaria Ferrari, Barbara Alicja Jereczek‐Fossa, Mohssen Ansarin, Giuseppe Sanguineti	10
13	Observational Multicenter Study on the Prognostic Relevance of Coagulation Activation in Risk Assessment and Stratification in Locally Advanced Breast Cancer. Outline of the ARIAS Trial 2020 ·Cancers ·Laura Pizzuti, Eriseld Krasniqi, Chiara Mandoj, Daniele Marinelli, Domenico Sergi, (unknown), G Paoletti, Claudio Botti, (unknown), Francesca Ferranti, Isabella Sperduti, Letizia Perracchio, Giuseppe Sanguineti, Paolo Marchetti, Gennaro Ciliberto, Giacomo Barchiesi, Marco Mazzotta, Maddalena Barba, Laura Conti, Patrizia Vici	2
14	Intravoxel incoherent motion diffusion-weighted imaging for oropharyngeal squamous cell carcinoma: Correlation with human papillomavirus Status 2019 ·European Journal of Radiology ·Antonello Vidiri, Simona Marzi, (unknown), Maria Benevolo, Francesca Rollo, Alessia Farneti, Laura Marucci, (unknown), Francesca Sperati, Francesca Di Giuliano, Raul Pellini, Giuseppe Sanguineti	15
15	Short course hypofractionated whole breast irradiation after conservative surgery: a single institution phase II study 2017 ·Journal of Experimental & Clinical Cancer Research ·Paola Pinnarò, C. Giordano, Alessia Farneti, Adriana Faiella, Giuseppe Iaccarino, Valeria Landoni, Diana Giannarelli, Patrizia Vici, Lidia Strigari, Giuseppe Sanguineti	3
16	Patient geometry‐driven information retrieval for IMRT treatment plan quality control 2009 ·Medical Physics ·Binbin Wu, Francesco Ricchetti, Giuseppe Sanguineti, Misha Kazhdan, Patricio Simari, Ming Chuang, Russell H. Taylor, Robert Jacques, Todd McNutt	238
17	Dosimetric Predictors of PEG Tube Dependency in Oropharyngeal Carcinoma after Exclusive IMRT 2008 ·International Journal of Radiation OncologyBiologyPhysics ·Nikhil G. Rao, (unknown), Eugene J. Endres, B. C. Parker, Marco Cianchetti, Giuseppe Sanguineti	0
18	Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck The following oncologists partcipated in this randomized study: Paolo Bruzzi, M.D., Isabella Ricci, M.D., Katia Donato, M.D., Franca Foppiano, Ph.D. (Istituto Nazionale per la Ricerca sul Cancro, Genova); Alida Santelli, M.D., Filippo Borasi, M.D. (Divisione of Otorinolaringoiatria–Ospedale San Martino, Genova); Enzo Mora, M.D., Marco Barbieri, M.D. (Clinica Otorinolaringoiatrica-Universita, Genova); Corrado Marziano, M.D., Renato Chiarlone, M.D., Fulvio Brema, M.D. (Ospedale S. Paolo, Savona); Giovanni Ricci, M.D., Andrea Grimaldi, M.D., Monica Cavallari, M.D. (Ospedale Galliera, Genova); Giammauro Numico, M.D. (Ospedale S. Croce e Carle, Cuneo, Italy). 2001 ·Cancer ·Renzo Corvò, Marco Benasso, Giuseppe Sanguineti, Rita Lionetto, Almalina Bacigalupo, G Margarino, E Pallestrini, Marco Merlano, Vito Vitale, Riccardo Rosso	2
19	Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck 2001 ·Cancer ·(unknown), Marco Benasso, Giuseppe Sanguineti, Rita Lionetto, Almalina Bacigalupo, G Margarino, E Pallestrini, Marco Merlano, Vito Vitale, Riccardo Rosso	48
20	Chemotherapy alternated with radiotherapy in the treatment of advanced head and neck carcinoma: predictive factors of outcome 1999 ·International Journal of Radiation OncologyBiologyPhysics ·Giuseppe Sanguineti, Renzo Corvò, Maria Pia Sormani, Marco Benasso, Gianmauro Numico, Almalina Bacigalupo, Riccardo Rosso, Vito Vitale	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact